Our data suggest that inhibition of BCR-ABL-induced leukemia by disrupting protein interactions could be possible, but would require blocking of multiple sites.
Because activated epidermal growth factor receptor signals through the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (mTOR) pathway, adding the oral mTOR inhibitor everolimus to erlotinib may improve efficacy by blocking multiple components of the same pathway.
Third, VEGF impacts hematopoiesis by blocking the differentiation of multiple hematopoietic lineages and inhibits the maturation of dendritic cells by reducing NF- κB activation [ 32, 39, 40].
Suppression of this pathway may also lead to attenuated cell migration and invasion by blocking multiple proteases degrading extracellular matrix [ 22].
Smac-mimetic IAP-antagonists induce TNFα-dependent apoptosin in several transformed cell lines [ 29- 31], and small molecule Smac-mimetics successfully sensitize TRAIL-induced apoptosis by blocking functions of IAPs in multiple cancer cells [ 11, 16, 32, 33].
Thus, given a block code, Shannon's theorem prohibits an arbitrary increase of the rate by taking blocks of multiple amino acid symbols.
Active anticancer components are known to exhibit a consistent antitumor effect by blocking abnormal expression alterations of multiple signaling proteins, such as VEGF, p53, JAK-STAT, and CDC14A [454 55] 55].
Nucleoside analogues 5-azacytidine (azacytidine) or 5-aza-2′-deoxycytidine (decitabine) can effectively reverse silencing of multiple TSGs by blocking the activity of DNA methyltransferase (DNMT) in tumor cells, thereby exhibiting significant tumor suppressive activity [73].
The initial rationale for the use of Bortezomib in multiple myeloma was inhibition of NF-κB activity by blocking proteasomal degradation of inhibitor of κBα [ 52].
Proteasome inhibitors have been used to treat multiple myeloma by blocking the degradation of proteins that inhibit the proliferation of cancer cells (Mahindra et al., 2012).
